News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current PER market cap is 72.12M. The company's latest EPS is AUD -0.0126 and P/E is -6.35.
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 587k | 741k | 633k | 1.78M | 1.58M |
| Operating Income | -3M | -5.93M | -8.05M | -5.83M | -11.77M |
| Net Income | -2.94M | -5.91M | -8.06M | -5.81M | -11.38M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 3.7M | 5.35M | 7M | 22.44M | 12.84M |
| Total Liabilities | 889k | 821k | 1.27M | 1.3M | 2.87M |
| Total Equity | 2.81M | 4.53M | 5.73M | 21.14M | 9.98M |
| Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -2.93M | -3.95M | -5.83M | -7.81M | -8.15M |
| Investing | 2.4M | -10k | -8k | -4k | -29k |
| Financing | 1.53M | 5.11M | 7.8M | 21.02M | -86k |
| Market Cap | 72.12M |
| Price to Earnings Ratio | -6.35 |
| Price to Sales Ratio | 44.44 |
| Price to Cash Ratio | 6.56 |
| Price to Book Ratio | 7.23 |
| Dividend Yield | - |
| Shares Outstanding | 901.54M |
| Average Volume (1 week) | 502.14k |
| Average Volume (1 Month) | 598.01k |
| 52 Week Change | 37.93% |
| 52 Week High | 0.11 |
| 52 Week Low | 0.053 |
| Spread (Intraday) | 0 (1.25%) |
| Company Name | Percheron Therapeutics Ltd |
| Address |
14 wallace avenue melbourne, victoria 3142 |
| Website | https://www.antisense.com.au |
| Industry | pharmaceutical diversified (H2) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
